Please login to the form below

Not currently logged in
Email:
Password:

ethics

This page shows the latest ethics news and features for those working in and with pharma, biotech and healthcare.

UK to launch world-first COVID-19 human challenge study in the ‘next few weeks’

UK to launch world-first COVID-19 human challenge study in the ‘next few weeks’

The world’s first COVID-19 human challenge study is set to begin in the UK within the next few weeks after receiving ethics approval, the government has announced.

Latest news

More from news
Approximately 2 fully matching, plus 131 partially matching documents found.

Latest Intelligence

  • Managing virtual teams Managing virtual teams

    These may sound trivial, but they can help maintain the work ethic when people are working from home on their own.

  • Mastering data protection in the pharma industry Mastering data protection in the pharma industry

    There has been considerable debate on this issue, and national ethics committees and regulatory bodies have struggled to reach consensus on whether processing should be on the basis of consent or

  • “Brexit has been a catalyst for UK clinical research... it’s turbocharged change” “Brexit has been a catalyst for UK clinical research... it’s turbocharged change”

    This success is based on some detailed troubleshooting in the existing approval mechanisms, resulting in a re-engineering of ethics and research approvals by the Health Research Authority (HRA).

  • China’s clinical trial shake-up China’s clinical trial shake-up

    When a serious adverse event occurs, the investigator must inform the sponsor, ethics committee and the National Medical Products Administration (NMPA). ... If the findings force the sponsor to stop the trial, it must tell the NMPA, investigators and the

  • AI UK – one year on AI UK – one year on

    To overcome these barriers, our research suggested that the public needed to see strong leadership around future ethics and regulation of AI in medicine and healthcare. ... Their declared preference was for such future tools to be developed instead under

More from intelligence
Approximately 0 fully matching, plus 21 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 29 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....